Voxalatamab

Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research.
Read more
€0.00 (tax incl.)
Reference:
HY-P99517
Product Details
HY-P99517

Data sheet

Size
Multiple sizes
Reactivity
CD3
Application
Cancer-programmed cell death
CAS
2411871-58-2

Menu

Settings